Bone battle: which drug wins for Steroid-Weakened bones?
NCT ID NCT06472050
First seen May 11, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study looked at 54 people who need long-term steroids and have weak bones (osteoporosis). It compared two treatments: first romosozumab then denosumab, versus denosumab alone for two years, then followed everyone on denosumab for two more years. The goal was to see which approach better improved bone density in the spine and hip over four years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Medicine, Tuen Mun Hospital
Hong Kong, China
Conditions
Explore the condition pages connected to this study.